Comments on Crisis Standards of Care Guidelines

10/14/2020

necessary, the context requiring their implementation very likely comes with an increased risk … that will help to manage resources broadly across geographic regions. The former may be focused on community …

/Advocacy/State-Advocacy/State-Regulatory-Comments/Comments-on-Crisis-Standards-of-Care-Guidelines/

2020 Committee Reports on Activities and Initiatives

10/14/2020

/Interim-Meeting/House-of-Delegates/2020-Committee-Reports-on-Activities-and-Initiatives/

2020 Informational Updates on Directives Referred for Implementation

10/14/2020

/Interim-Meeting/House-of-Delegates/2020-Informational-Updates-on-Directives-Referred-for-Implementation/

Massachusetts DPH Call Summary - October 7, 2020

10/13/2020

and Emergency Management participated in the discussion. MMS member questions for DPH officials were submitted … in the highest risk group and reduce the need for diagnostic testing. Physicians and patients should be aware … looking at the deployment of ancillary field capacity for managing patients, perhaps those who don't need …

/Patient-Care/COVID-19/Massachusetts-DPH-Call-Summary---October-7,-2020/

Committee on Preparedness - June 23, 2020

10/13/2020

Attendees Ritu Sarin, MD Kevin Ryan, MD Cassidy Boomsma, Medical Student Catherine Brown, DVM, MSc, MPH, Advisor Sarita Chung, MD, Advisor Alfred DeMaria, MD, Advisor Henry L. Dorkin, MD Eric Goralnick, MD, MS Kenneth Knowles, MD Julie Levison, MD, MPH Arya Mekkat, Medical Studen

/Governance-and-Leadership/Committees,-Task-Forces-and-Sections/Committee-on-Preparedness---June-23,-2020/

Comments Relative to Crisis Standards of Care Draft Planning Guidance

10/12/2020

their implementation very likely comes with an increased risk of infection to those putting themselves on the front … to manage resources broadly across geographic regions. The former may be focused on community investment …

/Advocacy/State-Advocacy/State-Regulatory-Comments/Comments-Relative-to-Crisis-Standards-of-Care-Draft-Planning-Guidance/

Committee on Violence Intervention and Prevention - June 15, 2020

10/11/2020

Attendees Adaugo Amobi, MD, MPH, Chair, presiding Elaine J. Alpert, MD, MPH Christopher E. Barsotti, MD Ylisabyth S. Bradshaw, DO, MS Fiona Danaher, MD Ms. Symren Dhaliwal Barbara Herbert, MD Ms. Margaret Igne Harriet (Robbins) Kantrowitz, RN Mr. Christopher Millman Deepika Sundararaj, MD Staff

/Governance-and-Leadership/Committees,-Task-Forces-and-Sections/Committee-on-Violence-Intervention-and-Prevention---June-15,-2020/

Committee on Geriatric Medicine - March 18, 2020

10/11/2020

Members Asif Merchant, MD, FACP, CMD, CPE, Chair, presiding Janet Jankowiak, MD Eric Reines, MD, FACP Dana Tripp Beth Warner, DO, CMD Chelsea Wong, MD Ms. Mariette Young Guests Stephanie Baker, MS, Senior Program Coordinator, Healthcentric Advisors Rosanna Bertrand, PhD, Division of Health and E

/Governance-and-Leadership/Committees,-Task-Forces-and-Sections/Committee-on-Geriatric-Medicine---March-18,-2020/

Letter to FDA Commissioner Hahn regarding REMS classification for mifepristone

10/7/2020

(FDA) to reevaluate the necessity of, and if maintained the composition of, the current Risk Evaluation … the first 70 days of gestation. Mifepristone has been proven safe and highly effective (97%) with minor risk … of complications (0.05%). Mifepristone is critical in managing early pregnancy loss. A 2018 study in the New …

/Advocacy/Federal-Advocacy/Federal-Advocacy-Letters/Letter-to-FDA-Commissioner-Hahn-regarding-REMS-classification-for-mifepristone/

Letter to FDA Commissioner Hahn regarding REMS classification for mifepristone (PDF)

10/7/2020

the composition of, the current Risk Evaluation Mitigation Strategies (REMS) classification for mifepristone … proven safe and highly effective (97%) with minor risk of complications (0.05%). Mifepristone … is critical in managing early pregnancy loss. A 2018 study in the New England Journal of Medicine …

/Advocacy/Federal-Advocacy/Federal-Advocacy-Letters/Letter-to-FDA-Commissioner-Hahn-regarding-REMS-classification-for-mifepristone-(PDF)/